BioSpace News Archive

VectivBio Holding AG announced the pricing of a follow-on public offering of 5,715,000 ordinary shares at a public offering price of $5.25 per share for aggregate gross proceeds of approximately $30 million, before deducting underwriting discounts and commissions and offering expenses.

Abiomed, Inc. (NASDAQ: ABMD) today announced that it will host an investor call on the heart failure opportunity with the Impella 5.5 and future Impella BTR heart pumps on June 24, 2022 from 2:30 p.m. – 3:30 p.m. ET.

Fennec Pharmaceuticals Inc. announced that the nominees listed in the management proxy circular dated April 20, 2022 for the Annual General Meeting of Shareholders were elected as directors of the Company at the Annual General Meeting of Shareholders held in New York, New York on June 14, 2022.

Lytus Technologies Holdings PTV. Ltd. (the “Company”), a platform technology services company with nearly 8 million users and with operations in the USA and India, today announced the pricing of its initial public offering of 2,609,474 common shares at a public offering price of $4.75 per share, for gross proceeds of approximately $12.4 million, before deducting offering expenses.